


Healthcare News Roundup: Regulatory
HSMN NewsFeed - 17 Oct 2006
Genasense(R) Receives Orphan Drug Designation in Australia for Patients With Advanced Melanoma
Genasense(R) Receives Orphan Drug Designation in Australia for Patients With Advanced Melanoma
HSMN NewsFeed - 16 Oct 2006
InfaCare Pharmaceutical Appoints Dr. Ronald Dundore, Vice President of Regulatory and Quality Affairs
InfaCare Pharmaceutical Appoints Dr. Ronald Dundore, Vice President of Regulatory and Quality Affairs
HSMN NewsFeed - 13 Oct 2006
BioAlliance Pharma Receives Marketing Authorisation for Its First Product, Loramyc(R)
BioAlliance Pharma Receives Marketing Authorisation for Its First Product, Loramyc(R)
HSMN NewsFeed - 12 Oct 2006
Peregrine Receives Regulatory Approval for New Cotara(R) Brain Cancer Clinical Trial
Peregrine Receives Regulatory Approval for New Cotara(R) Brain Cancer Clinical Trial
HSMN NewsFeed - 6 Oct 2006
SUBOXONE(R) (Buprenorphine/Naloxone) Approved In European Union for Treatment of Opioid Dependence
SUBOXONE(R) (Buprenorphine/Naloxone) Approved In European Union for Treatment of Opioid Dependence
HSMN NewsFeed - 5 Oct 2006
Conor Medsystems Receives Approval for One-Year Shelf Life for CoStar(R) Stent in the European Union
Conor Medsystems Receives Approval for One-Year Shelf Life for CoStar(R) Stent in the European Union
HSMN NewsFeed - 4 Oct 2006
Medtronic Announces Regulatory Approval for the Endeavor Drug-Eluting Coronary Stent System in Australia
Medtronic Announces Regulatory Approval for the Endeavor Drug-Eluting Coronary Stent System in Australia
HSMN NewsFeed - 4 Oct 2006
St. Jude Medical Announces European Approval of Atlas II ICD and Atlas II Heart Failure Devices
St. Jude Medical Announces European Approval of Atlas II ICD and Atlas II Heart Failure Devices
HSMN NewsFeed - 3 Oct 2006
TransMedics Receives European Union CE Marking Designation for its Organ Care System
TransMedics Receives European Union CE Marking Designation for its Organ Care System
HSMN NewsFeed - 2 Oct 2006
Ipsen: EMEA's Validation of Febuxostat's Marketing Authorization Application in the European Union
Ipsen: EMEA's Validation of Febuxostat's Marketing Authorization Application in the European Union
HSMN NewsFeed - 2 Oct 2006
Genzyme Receives European Approval for Synvisc(R) In Ankle and Shoulder Osteoarthritis Indications
Genzyme Receives European Approval for Synvisc(R) In Ankle and Shoulder Osteoarthritis Indications
HSMN NewsFeed - 25 Sep 2006
Approval of FOSRENOL in the United Kingdom triggers U.S.$3 million payment to AnorMED
Approval of FOSRENOL in the United Kingdom triggers U.S.$3 million payment to AnorMED
HSMN NewsFeed - 22 Sep 2006
European Commission Approves GARDASIL(R), Merck's Cervical Cancer Vaccine
European Commission Approves GARDASIL(R), Merck's Cervical Cancer Vaccine
HSMN NewsFeed - 20 Sep 2006
Gen-Probe Responds to FDA Questions on TIGRIS(R) / West Nile Virus Regulatory Application
Gen-Probe Responds to FDA Questions on TIGRIS(R) / West Nile Virus Regulatory Application
HSMN NewsFeed - 20 Sep 2006
Facet Solutions, Inc. Receives CE Mark Approval for the Anatomic Facet Replacement Spinal Implant System
Facet Solutions, Inc. Receives CE Mark Approval for the Anatomic Facet Replacement Spinal Implant System
HSMN NewsFeed - 19 Sep 2006
St. Jude Medical Announces FDA and European CE Mark Approvals of Tendril ST(R) Pacemaker Lead
St. Jude Medical Announces FDA and European CE Mark Approvals of Tendril ST(R) Pacemaker Lead
HSMN NewsFeed - 12 Sep 2006
Biopure's Marketing Application for Hemopure(R) Accepted for Review In United Kingdom
Biopure's Marketing Application for Hemopure(R) Accepted for Review In United Kingdom
HSMN NewsFeed - 12 Sep 2006
Q-Med: Q-Med's First Product in the Field of Body Augmentations, MACROLANE, Approved in Europe
Q-Med: Q-Med's First Product in the Field of Body Augmentations, MACROLANE, Approved in Europe
HSMN NewsFeed - 9 Sep 2006
OptiMedica Receives ISO Certification and CE Mark for the PASCAL(R) Photocoagulator
OptiMedica Receives ISO Certification and CE Mark for the PASCAL(R) Photocoagulator
HSMN NewsFeed - 6 Sep 2006
First Drug-Eluting Stent Approved in Europe for Most Severe Form of Arterial Disease in the Leg
First Drug-Eluting Stent Approved in Europe for Most Severe Form of Arterial Disease in the Leg
